生物制药公司Atrium Therapeutics Inc披露了其第一季度财务数据,显示该季度运营费用总计3691.5万美元。这一数字反映了公司在研发及日常运营方面的持续投入。
生物制药公司Atrium Therapeutics Inc披露了其第一季度财务数据,显示该季度运营费用总计3691.5万美元。这一数字反映了公司在研发及日常运营方面的持续投入。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.